These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34061827)

  • 1. High-throughput framework for genetic analyses of adverse drug reactions using electronic health records.
    Zheng NS; Stone CA; Jiang L; Shaffer CM; Kerchberger VE; Chung CP; Feng Q; Cox NJ; Stein CM; Roden DM; Denny JC; Phillips EJ; Wei WQ
    PLoS Genet; 2021 Jun; 17(6):e1009593. PubMed ID: 34061827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-genome sequencing in pharmacogenetics.
    Urban TJ
    Pharmacogenomics; 2013 Mar; 14(4):345-8. PubMed ID: 23438878
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity.
    Chan SL; Jin S; Loh M; Brunham LR
    Pharmacogenomics; 2015; 16(10):1161-78. PubMed ID: 25978008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide and Phenome-wide Approaches to Understand Variable Drug Actions in Electronic Health Records.
    Robinson JR; Denny JC; Roden DM; Van Driest SL
    Clin Transl Sci; 2018 Mar; 11(2):112-122. PubMed ID: 29148204
    [No Abstract]   [Full Text] [Related]  

  • 5. PheMap: a multi-resource knowledge base for high-throughput phenotyping within electronic health records.
    Zheng NS; Feng Q; Kerchberger VE; Zhao J; Edwards TL; Cox NJ; Stein CM; Roden DM; Denny JC; Wei WQ
    J Am Med Inform Assoc; 2020 Nov; 27(11):1675-1687. PubMed ID: 32974638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing.
    Lauschke VM; Ingelman-Sundberg M
    Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of Adverse Drug Reactions.
    Osanlou O; Pirmohamed M; Daly AK
    Adv Pharmacol; 2018; 83():155-190. PubMed ID: 29801574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology.
    Ross CJ; Visscher H; Sistonen J; Brunham LR; Pussegoda K; Loo TT; Rieder MJ; Koren G; Carleton BC; Hayden MR;
    Thyroid; 2010 Jul; 20(7):681-7. PubMed ID: 20578893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SWEDEGENE-a Swedish nation-wide DNA sample collection for pharmacogenomic studies of serious adverse drug reactions.
    Hallberg P; Yue QY; Eliasson E; Melhus H; Ås J; Wadelius M
    Pharmacogenomics J; 2020 Aug; 20(4):579-585. PubMed ID: 31949290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam.
    Campbell C; McCormack M; Patel S; Stapleton C; Bobbili D; Krause R; Depondt C; Sills GJ; Koeleman BP; Striano P; Zara F; Sander JW; Lerche H; Kunz WS; Stefansson K; Stefansson H; Doherty CP; Heinzen EL; Scheffer IE; Goldstein DB; O'Brien T; Cotter D; Berkovic SF; ; Sisodiya SM; Delanty N; Cavalleri GL
    Epilepsia; 2022 Jun; 63(6):1563-1570. PubMed ID: 35298028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights from genome-wide association studies of drug response.
    Zhou K; Pearson ER
    Annu Rev Pharmacol Toxicol; 2013; 53():299-310. PubMed ID: 23072379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics and variable drug response.
    Wilke RA; Dolan ME
    JAMA; 2011 Jul; 306(3):306-7. PubMed ID: 21771992
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical association between pharmacogenomics and adverse drug reactions.
    Zhou ZW; Chen XW; Sneed KB; Yang YX; Zhang X; He ZX; Chow K; Yang T; Duan W; Zhou SF
    Drugs; 2015 Apr; 75(6):589-631. PubMed ID: 25895462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Zealand platform to enable genetic investigation of adverse drug reactions.
    Maggo SD; Chua EW; Chin P; Cree S; Pearson J; Doogue M; Kennedy MA
    N Z Med J; 2017 Dec; 130(1466):62-69. PubMed ID: 29197902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of New Genomic Technologies on Understanding Adverse Drug Reactions.
    Maggo SD; Savage RL; Kennedy MA
    Clin Pharmacokinet; 2016 Apr; 55(4):419-36. PubMed ID: 26369774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics for personalized pain medicine.
    Ko TM; Wong CS; Wu JY; Chen YT
    Acta Anaesthesiol Taiwan; 2016 Mar; 54(1):24-30. PubMed ID: 26976339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying adverse drug reactions from free-text electronic hospital health record notes.
    Wasylewicz A; van de Burgt B; Weterings A; Jessurun N; Korsten E; Egberts T; Bouwman A; Kerskes M; Grouls R; van der Linden C
    Br J Clin Pharmacol; 2022 Mar; 88(3):1235-1245. PubMed ID: 34468999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THE CHALLENGES IN USING ELECTRONIC HEALTH RECORDS FOR PHARMACOGENOMICS AND PRECISION MEDICINE RESEARCH.
    Laper SM; Restrepo NA; Crawford DC
    Pac Symp Biocomput; 2016; 21():369-80. PubMed ID: 26776201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomics of Adverse Drug Reactions.
    Alfirevic A; Pirmohamed M
    Trends Pharmacol Sci; 2017 Jan; 38(1):100-109. PubMed ID: 27955861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast Screening Technology for Drug Emergency Management: Predicting Suspicious SNPs for ADR with Information Theory-based Models.
    Liang Z; Liu J; Huang JX; Zeng X
    Comb Chem High Throughput Screen; 2018; 21(2):93-99. PubMed ID: 29336255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.